76 related articles for article (PubMed ID: 2684368)
1. [Screening of antibodies to human T-cell leukemia virus type I (HTLV-I) in sera of blood donors and comparison of different methods].
Fan FS; Lin DL; Yeh HM; Chen MS; Su JL; Lin SH; Tzeng CH; Chuang MW; Liu JH; Hsieh RK
Zhonghua Yi Xue Za Zhi (Taipei); 1989 Jul; 44(1):71-6. PubMed ID: 2684368
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of anti-HTLV-1 in physical-checkup individuals and blood donors in Taiwan.
Yung CH; Chow MP; Hu HY; Tzeng JL; Wu YS; Lyou JY; Liu WT
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov; 25(4):244-51. PubMed ID: 1342641
[TBL] [Abstract][Full Text] [Related]
3. [Serological evaluation of human T lymphotropic virus type-I infection in routine hospital samples, especially using serodia.HTLV-I].
Kamihira S; Nakashima S; Fukahori Y; Toriya K; Kanamura M; Ohta T
Rinsho Byori; 1990 Jul; 38(7):783-8. PubMed ID: 2205742
[TBL] [Abstract][Full Text] [Related]
4. Immunofluorescence, enzyme-linked immunosorbent assay, particle agglutination and western blot for the detection of antibody to human immunodeficiency virus type 1.
Auwanit W; Ayuthaya PI; Balachandra K; Jayavasu C; Phanthumachinda B; Ikuta K; Yamanishi K; Kanai K
Southeast Asian J Trop Med Public Health; 1990 Mar; 21(1):53-9. PubMed ID: 2205928
[TBL] [Abstract][Full Text] [Related]
5. Comparative diagnostic assay results for detecting antibody to HTLV-I in Japanese blood donor samples: higher positivity rates by particle agglutination assay [corrected].
Ishizaki J; Okayama A; Tachibana N; Yokota T; Shishime E; Tsuda K; Mueller N
J Acquir Immune Defic Syndr (1988); 1988; 1(4):340-5. PubMed ID: 3063808
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of commercially available particle agglutination assay and enzyme-linked immunosorbent assay for screening of human T-cell leukemia virus type I antibodies in blood donors.
Kobayashi S; Yoshida T; Hiroshige Y; Matsui T; Yamamoto N
J Clin Microbiol; 1988 Feb; 26(2):308-12. PubMed ID: 2893807
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the confirmatory test by western blotting assay (WB) for the detection of antibodies to adult T-cell leukemia virus type I. Analysis of the discrepancy between indirect immunofluorescence assay (IF), enzyme immunoassay (EIA) and gelatin particle agglutination assay (PA)].
Nishimura Y; Yamaguchi K; Takatsuki K; Kiyokawa T; Imamura Y; Fujiwara H
Rinsho Byori; 1989 Apr; 37(4):385-9. PubMed ID: 2664283
[No Abstract] [Full Text] [Related]
8. Performance certification of gelatin particle agglutination assay for anti-HTLV-1 antibody: inconclusive positive results.
Maeda Y; Imai J; Kiyokawa H; Kanamura M; Hino S
Jpn J Cancer Res; 1989 Oct; 80(10):915-9. PubMed ID: 2515175
[TBL] [Abstract][Full Text] [Related]
9. [Significance of the confirmatory test of enzyme immunoassay and western blotting method in detection of anti-HTLV-1 in sera].
Oita T; Fukuda K; Kasakura S
Rinsho Byori; 1989 Jul; 37(7):774-8. PubMed ID: 2691735
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of human T-cell lymphotropic virus type I among Dutch blood donors].
Zaaijer HL; Dudok de Wit C; Cuypers HT; Winkel IN; Lelie PN
Ned Tijdschr Geneeskd; 1993 Dec; 137(49):2541-3. PubMed ID: 8272141
[TBL] [Abstract][Full Text] [Related]
11. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
[TBL] [Abstract][Full Text] [Related]
13. HTLV-1 in Switzerland: low prevalence of specific antibodies in HIV risk groups, high prevalence of cross-reactive antibodies in normal blood donors.
Schüpbach J; Baumgartner A; Tomasik Z
Int J Cancer; 1988 Dec; 42(6):857-62. PubMed ID: 3192331
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the human T-cell leukemia virus type I seropositivity of blood donors by the particle agglutination inhibition test.
Kwon KW; Ikeda H; Yano M; Sekiguchi S
Jpn J Cancer Res; 1989 Sep; 80(9):833-9. PubMed ID: 2513300
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of immunoglobulin M and G Western blot and ELISA for screening antibodies to Treponema pallidum in blood donors.
Wang LN; Li JM
Sex Transm Dis; 2009 Jul; 36(7):413-6. PubMed ID: 19387420
[TBL] [Abstract][Full Text] [Related]
16. [Detection of HTLV-I viral antibodies in donor blood samples].
Iakovleva LS; Seniuta NB; Stepina VN; Gurtsevich VE; Buachidze LN
Vopr Virusol; 1989; 34(2):174-6. PubMed ID: 2669334
[TBL] [Abstract][Full Text] [Related]
17. Prevention of transmission of human T-lymphotropic virus type 1 (HTLV-1) through transfusion, by donor screening with antibody to the virus. One-year experience.
Inaba S; Sato H; Okochi K; Fukada K; Takakura F; Tokunaga K; Kiyokawa H; Maeda Y
Transfusion; 1989 Jan; 29(1):7-11. PubMed ID: 2643213
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to human T-cell lymphotropic virus type I (HTLV-I) by particle agglutination (PA) test in Korean blood donors.
Kim JM; Song YG; Oho YC; Park HC; Kwon KH; Kim E; Lee SH; Kim KH
Yonsei Med J; 1999 Apr; 40(2):173-7. PubMed ID: 10333722
[TBL] [Abstract][Full Text] [Related]
19. [Pretransfusion screening tests for HIV and HTLV-I in donated blood].
Okubo S
Rinsho Byori; 1989 Jul; 37(7):762-7. PubMed ID: 2607646
[TBL] [Abstract][Full Text] [Related]
20. [Search for antibodies against human T-cell lymphotropic virus type I (HTLV-I) in blood donors and risk groups].
Silva Cabrera E; Pérez Guevara MT; Lubián Caballero AL; de la Fuente Arzola JL; Navea Leyva L; Cruz Sui O
Rev Cubana Med Trop; 1997; 49(1):24-7. PubMed ID: 9685956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
